Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYMEWORKS INC (US)

16.30
-0.0600-0.37%
Post-market: 16.300.00000.00%17:33 EDT
Volume:521.16K
Turnover:8.49M
Market Cap:1.23B
PE:-16.66
High:16.61
Open:16.44
Low:16.06
Close:16.36
52wk High:17.70
52wk Low:9.03
Shares:75.58M
Float Shares:38.30M
Volume Ratio:0.67
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9781
EPS(LYR):-1.6177
ROE:-19.89%
ROA:-11.19%
PB:3.68
PE(LYR):-10.08

Loading ...

Zymeworks Inc. Receives FDA Clearance for Investigational New Drug Application for ZW251, Targeting Hepatocellular Carcinoma

Reuters
·
Jul 28

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate

THOMSON REUTERS
·
Jul 28

Zymeworks Inc. Unveils Presentation on Advancements in Targeted Therapies for Cancer and Autoimmune Diseases

Reuters
·
Jul 08

Zymeworks Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
Jul 03

Zymeworks Inc. Amends Pre-Funded Warrants and Purchasers Net Exercise Warrants for 5.1 Million Shares

Reuters
·
Jun 28

BRIEF-Zymeworks' Zanidatamab Approved in China for HER2-High Expression Biliary Tract Cancer

Reuters
·
May 30

Zymeworks Inc. Secures NMPA Approval for Zanidatamab in China, Set to Receive $20 Million Milestone Payment from BeOne Medicines

Reuters
·
May 30

Zymeworks Inc. to Present Oncology Portfolio at Upcoming ASCO Annual Meeting

Reuters
·
May 23

Zymeworks Inc. to Participate in Goldman Sachs Global Healthcare Conference

Reuters
·
May 21

Zymeworks Initiated at Buy by TD Securities

Dow Jones
·
May 20

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
May 20

TD Cowen Initiates Coverage on Zymeworks With Buy Rating

MT Newswires Live
·
May 20

EcoR1 Capital Reports Acquisition of Common Shares in Zymeworks Inc

Reuters
·
May 20

Zymeworks Shows Positive Preclinical Data for Experimental Respiratory Imflammation Treatment

MT Newswires Live
·
May 20

Zymeworks Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Zymeworks Q1 EPS $(0.30) Beats $(0.41) Estimate, Sales $27.11M Beat $20.65M Estimate

Benzinga
·
May 09

BRIEF-Zymeworks Q1 Operating Expenses USD 52.723 Million

Reuters
·
May 09

Zymeworks Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
May 07

Press Release: Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development

Dow Jones
·
Apr 21

Couchbase, Staar Surgical, Zymeworks, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
Apr 12